Drug profile · INN
cetirizine hydrochloride
CETIRIZINE HYDROCHLORIDE ALLERGY
cetirizine hydrochloride (CETIRIZINE HYDROCHLORIDE ALLERGY) is a histamine h1 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — cetirizine hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 6
- Data quality
- 0.89
Quick answer
cetirizine hydrochloride (CETIRIZINE HYDROCHLORIDE ALLERGY) is a histamine h1 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cetirizine hydrochloride?
cetirizine hydrochloride (CETIRIZINE HYDROCHLORIDE ALLERGY) is a histamine h1 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for cetirizine hydrochloride?
CETIRIZINE HYDROCHLORIDE ALLERGY is a marketed brand name for cetirizine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cetirizine hydrochloride?
cetirizine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.